These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15261605)

  • 1. Dementia in Parkinson's disease: common and treatable.
    McKeith I
    Lancet Neurol; 2004 Aug; 3(8):456. PubMed ID: 15261605
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease dementia--a first step?
    Press DZ
    N Engl J Med; 2004 Dec; 351(24):2547-9. PubMed ID: 15590960
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivastigmine in Parkinson's disease dementia: profile report.
    Siddiqui MA; Wagstaff AJ
    Drugs Aging; 2007; 24(3):255-9. PubMed ID: 17362052
    [No Abstract]   [Full Text] [Related]  

  • 4. Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
    Vidal EI; Fukushima FB; Valle AP; Villas Boas PJ
    J Am Geriatr Soc; 2013 Jan; 61(1):170-2. PubMed ID: 23311565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dementia in Parkinson's disease].
    Halvorsen Ø; Tysnes OB
    Tidsskr Nor Laegeforen; 2007 Oct; 127(19):2517-20. PubMed ID: 17925819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life].
    Lökk J; Winblad B
    Lakartidningen; 2006 Feb 15-21; 103(7):451-5. PubMed ID: 16535872
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivastigmine in Parkinson's disease dementia.
    Chitnis S; Rao J
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular contribution to dementia in Parkinson's disease.
    Korczyn AD
    Neurodegener Dis; 2010; 7(1-3):127-30. PubMed ID: 20173342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution and profile of dementia in Parkinson's disease.
    Ross HF; Hughes TA; Boyd JL; Biggins CA; Madeley P; Mindham RH; Spokes EG
    Adv Neurol; 1996; 69():343-7. PubMed ID: 8615150
    [No Abstract]   [Full Text] [Related]  

  • 10. Dementia in Parkinson's disease.
    Robottom BJ; Weiner WJ
    Int Rev Neurobiol; 2009; 84():229-44. PubMed ID: 19501721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease and dementia.
    Agid Y; Ruberg M; Dubois B; Pillon B; Cusimano G; Raisman R; Cash R; Lhermitte F; Javoy-Agid F
    Clin Neuropharmacol; 1986; 9 Suppl 2():S22-36. PubMed ID: 2885087
    [No Abstract]   [Full Text] [Related]  

  • 12. Dementia in Parkinson's disease.
    Aarsland D; Beyer MK; Kurz MW
    Curr Opin Neurol; 2008 Dec; 21(6):676-82. PubMed ID: 18989112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal estrogen use and Parkinson's disease with and without dementia.
    Marder K; Tang MX; Alfaro B; Mejia H; Cote L; Jacobs D; Stern Y; Sano M; Mayeux R
    Neurology; 1998 Apr; 50(4):1141-3. PubMed ID: 9566410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in Parkinson's disease.
    Girotti F; Marano R; Grazzi L; Scigliano G; Caraceni T
    J Neural Transm Suppl; 1986; 22():163-70. PubMed ID: 3465870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenetic and therapeutic aspects of dementia in Parkinson's disease].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):73-7. PubMed ID: 19385124
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia and mild cognitive impairment in patients with Parkinson's disease.
    Teive HA; Piovesan MR; Werneck LC
    Arq Neuropsiquiatr; 2009 Dec; 67(4):1165; author reply 1165. PubMed ID: 20073125
    [No Abstract]   [Full Text] [Related]  

  • 18. [Emotional and cognitive disorders in Parkinson disease].
    Arsland D; Larsen JP
    Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing].
    Larsson A
    Lakartidningen; 2006 May 10-16; 103(19):1537; discussion 1537-8. PubMed ID: 16805251
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits of rivastigmine on attention in dementia associated with Parkinson disease.
    Wesnes KA; McKeith I; Edgar C; Emre M; Lane R
    Neurology; 2005 Nov; 65(10):1654-6. PubMed ID: 16301500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.